Show simple item record

dc.contributor.authorEnnker, J.
dc.contributor.authorAlbert, A.
dc.contributor.authorFlorath, Ines
dc.identifier.citationEnnker, J. and Albert, A. and Florath, I. 2010. Medtronic stentless Freestyle® porcine aortic valve replacement. In Aortic Root Surgery: The Biological Solution, 366-385: Steinkopff.

Biological heart valve prostheses offer the opportunity of avoiding the risk of thromboembolic and hemorrhagic complications due to anticoagulation therapy. Current indications recommend a bioprosthesis for aortic valve replacement in patients of any age, who will not take warfarin or who have major medical contraindications to anticoagulation therapy (Class I), in patients older than 65 years without risk factors for thromboembolism (Class IIa) and in patients under 65 years for lifestyle considerations after detailed discussion of the risks of anticoagulation versus the likelihood of a second valve replacement [1]. © 2010 Steinkopff.

dc.titleMedtronic stentless Freestyle® porcine aortic valve replacement
dc.typeBook Chapter
dcterms.source.titleAortic Root Surgery: The Biological Solution
curtin.departmentEpidemiology and Biostatistics
curtin.accessStatusFulltext not available

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record